REQUEST A DEMO
Total
USD $0.00
Search more companies

Incheon Pharmaceutical Co.,Ltd. (South Korea)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Incheon Pharmaceutical Co.,Ltd. Profile Updated: February 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Incheon Pharmaceutical Co.,Ltd. is an enterprise in South Korea, with the main office in Incheon. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on March 21, 1997. It currently has a total number of 472 (2026) employees. From the latest financial highlights, Incheon Pharmaceutical Co.,Ltd. reported a net sales revenue increase of 8.05% in 2024. Its total assets grew by 16.21% over the same period. Incheon Pharmaceutical Co.,Ltd.’s net profit margin decreased by 0.1% in 2024.

Headquarters
Ilsin-ro Bupyeong-gu Incheon, 85-2
Incheon; Incheon;

Contact Details: Purchase the Incheon Pharmaceutical Co.,Ltd. report to view the information.

Website: http://inchunpharm.com

Basic Information
Total Employees:
Purchase the Incheon Pharmaceutical Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Incheon Pharmaceutical Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Incheon Pharmaceutical Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Incheon Pharmaceutical Co.,Ltd. report to view the information.
Incorporation Date:
March 21, 1997
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
23.2%
Purchase this report to view the information.
22.4%
Purchase this report to view the information.
21.3%
Subsidiaries
Sg-Medipharm.Com
Company Performance
Financial values in the chart are available after Incheon Pharmaceutical Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
8.05%
Total operating revenue
8.05%
Operating Profit/Loss (EBIT)
3.25%
EBITDA
5.84%
Net Profit/Loss for the Period
-7.15%
Total Assets
16.21%
Total Equity
8.4%
Operating Profit Margin (ROS)
-0.03%
Net Profit Margin
-0.1%
Return on Equity (ROE)
-1.52%
Debt/Equity
12.32%
Quick Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?